Enhancement of voltage-gated K+ channels and depression of voltage-gated Ca2+ channels are involved in quercetin-induced vasorelaxation in rat coronary artery

Planta Medica

Volumn 80, Issue 6, 2014, Pages 465-472

  Hou, Xiaomin ^a   Liu, Yu ^a   Niu, Longgang ^a   Cui, Lijuan ^a   Zhang, Mingsheng ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

L type voltage gated calcium channels; quercetin; rat coronary artery; vasorelaxation; voltage gated potassium channels

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 AMINOPYRIDINE; BARIUM CHLORIDE; CALCIUM ION; GLIBENCLAMIDE; IBERIOTOXIN; N(G) NITROARGININE METHYL ESTER; POTASSIUM CHLORIDE; PROSTAGLANDIN F3 ALPHA; QUERCETIN; THROMBOXANE A2 DERIVATIVE; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; ANILINE DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; FLUO 4; PLANT EXTRACT; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; VASODILATOR AGENT; XANTHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CORONARY ARTERY; DEPRESSION; DRUG MECHANISM; ELECTRIC ACTIVITY; ENDOTHELIUM; MALE; MOLECULAR PROBE; MYOGRAPHY; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; VASODILATATION; WHOLE CELL PATCH CLAMP; ANIMAL; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECTS; METABOLISM; MUSCLE CONTRACTION; PATCH CLAMP TECHNIQUE; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

RATTUS;

4-AMINOPYRIDINE; ANILINE COMPOUNDS; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CORONARY VESSELS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; PLANT EXTRACTS; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, VOLTAGE-GATED; QUERCETIN; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS; XANTHENES;

EID: 84899479531     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1368320     Document Type: Article

References (46)

1. Erlund I., Freese R., Marniemi J., Hakala P., Alfthan G. Bioavailability of quercetin from berries and the diet. Nutr Cancer: 2006; 54 13 17
2. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., Hakulinen T., Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr: 2002; 76 560 568
3. Zamora-Ros R., Jimenez C., Cleries R., Agudo A., Sanchez M. J., Sanchez-Cantalejo E., Molina-Montes E., Navarro C., Chirlaque M. D., Maria Huerta J., Amiano P., Redondo M. L., Barricarte A., Gonzalez C. A. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology: 2013; 24 726 733
4. Russo M., Spagnuolo C., Tedesco I., Bilotto S., Russo G. L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol: 2012; 83 6 15
5. de Whalley C. V., Rankin S. M., Hoult J. R., Jessup W., Leake D. S. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol: 1990; 39 1743 1750
6. Mann G. E., Rowlands D. J., Li F. Y., de Winter P., Siow R. C. Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res: 2007; 75 261 274
7. Ertug P. U., Aydinoglu F., Goruroglu Ozturk O., Singirik E., Ogulener N. Comparative study of the quercetin, ascorbic acid, glutathione and superoxide dismutase for nitric oxide protecting effects in mouse gastric fundus. Eur J Pharmacol: 2013; 698 379 387
8. Lopez-Lopez G., Moreno L., Cogolludo A., Galisteo M., Ibarra M., Duarte J., Lodi F., Tamargo J., Perez-Vizcaino F. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol Pharmacol: 2004; 65 851 859
9. Pignatelli P., Pulcinelli F. M., Celestini A., Lenti L., Ghiselli A., Gazzaniga P. P., Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr: 2000; 72 1150 1155
10. Mahmoud M. F., Hassan N. A., El Bassossy H. M., Fahmy A. Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One: 2013; 8 e63784
11. Das D. K., Chakraborty A., Sinha M., Manna K., Mukherjee D., Chakraborty A., Bhattacharjee S., Dey S. Modulatory role of quercetin against gamma radiation-mediated biochemical and morphological alterations of red blood cells. Int J Radiat Biol: 2013; 89 471 481
12. Liu C. J., Lin J. Y. Anti-inflammatory effects of phenolic extracts from strawberry and mulberry fruits on cytokine secretion profiles using mouse primary splenocytes and peritoneal macrophages. Int Immunopharmacol: 2013; 16 165 170
13. Moon J., Lee S. M., Do H. J., Cho Y., Chung J. H., Shin M. J. Quercetin up-regulates LDL receptor expression in HepG2 cells. Phytother Res: 2012; 26 1688 1694
14. Shen Y., Ward N. C., Hodgson J. M., Puddey I. B., Wang Y., Zhang D., Maghzal G. J., Stocker R., Croft K. D. Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1. Free Radic Biol Med: 2013; 65 908 915
15. Bardy G., Virsolvy A., Quignard J. F., Ravier M. A., Bertrand G., Dalle S., Cros G., Magous R., Richard S., Oiry C. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol: 2013; 169 1102 1113
16. Soleas G. J., Grass L., Josephy P. D., Goldberg D. M., Diamandis E. P. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem: 2002; 35 119 124
17. Kressler J., Millard-Stafford M., Warren G. L. Quercetin and endurance exercise capacity: a systematic review and meta-analysis. Med Sci Sports Exerc: 2011; 43 2396 2404
18. Jalili T., Carlstrom J., Kim S., Freeman D., Jin H., Wu T. C., Litwin S. E., David Symons J. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J Cardiovasc Pharmacol: 2006; 47 531 541
19. Jin H. B., Yang Y. B., Song Y. L., Zhang Y. C., Li Y. R. Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats. Mol Biol Rep: 2012; 39 11005 11009
20. Annapurna A., Reddy C. S., Akondi R. B., Rao S. R. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. J Pharm Pharmacol: 2009; 61 1365 1374
21. Bartekova M., Carnicka S., Pancza D., Ondrejcakova M., Breier A., Ravingerova T. Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia. Can J Physiol Pharmacol: 2010; 88 465 471
22. Lodi F., Jimenez R., Moreno L., Kroon P. A., Needs P. W., Hughes D. A., Santos-Buelga C., Gonzalez-Paramas A., Cogolludo A., Lopez-Sepulveda R., Duarte J., Perez-Vizcaino F. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis: 2009; 204 34 39
23. Loke W. M., Hodgson J. M., Proudfoot J. M., McKinley A. J., Puddey I. B., Croft K. D. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr: 2008; 88 1018 1025
24. Pashevin D. A., Tumanovska L. V., Dosenko V. E., Nagibin V. S., Gurianova V. L., Moibenko A. A. Antiatherogenic effect of quercetin is mediated by proteasome inhibition in the aorta and circulating leukocytes. Pharmacol Rep: 2011; 63 1009 1018
25. Moon S. K., Cho G. O., Jung S. Y., Gal S. W., Kwon T. K., Lee Y. C., Madamanchi N. R., Kim C. H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun: 2003; 301 1069 1078
26. Oak M. H., El Bedoui J., Schini-Kerth V. B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem: 2005; 16 1 8
27. Perez-Vizcaino F., Ibarra M., Cogolludo A. L., Duarte J., Zaragoza-Arnaez F., Moreno L., Lopez-Lopez G., Tamargo J. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J Pharmacol Exp Ther: 2002; 302 66 72
28. Ibarra M., Perez-Vizcaino F., Cogolludo A., Duarte J., Zaragoza-Arnaez F., Lopez-Lopez J. G., Tamargo J. Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria. Planta Med: 2002; 68 307 310
29. Ajay M., Achike F. I., Mustafa A. M., Mustafa M. R. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract: 2006; 73 1 7
30. Xiong Z., Sperelakis N. Regulation of L-type calcium channels of vascular smooth muscle cells. J Mol Cell Cardiol: 1995; 27 75 91
31. Saponara S., Sgaragli G., Fusi F. Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels. Eur J Pharmacol: 2008; 598 75 80
32. Fusi F., Saponara S., Pessina F., Gorelli B., Sgaragli G. Effects of quercetin and rutin on vascular preparations: a comparison between mechanical and electrophysiological phenomena. Eur J Nutr: 2003; 42 10 17
33. Saponara S., Sgaragli G., Fusi F. Quercetin as a novel activator of L-type Ca(2+) channels in rat tail artery smooth muscle cells. Br J Pharmacol: 2002; 135 1819 1827
34. Martin P., Rebolledo A., Palomo A. R., Moncada M., Piccinini L., Milesi V. Diversity of potassium channels in human umbilical artery smooth muscle cells: a review of their roles in human umbilical artery contraction. Reprod Sci: 2013; 10.1177/1933719113504468
35. Dick G. M., Tune J. D. Role of potassium channels in coronary vasodilation. Exp Biol Med (Maywood): 2010; 235 10 22
36. Cogolludo A., Frazziano G., Briones A. M., Cobeno L., Moreno L., Lodi F., Salaices M., Tamargo J., Perez-Vizcaino F. The dietary flavonoid quercetin activates BKCa currents in coronary arteries via production of H2O2. Role in vasodilatation. Cardiovasc Res: 2007; 73 424 431
37. Iozzi D., Schubert R., Kalenchuk V. U., Neri A., Sgaragli G., Fusi F., Saponara S. Quercetin relaxes rat tail main artery partly via a PKG-mediated stimulation of KCa 1.1 channels. Acta Physiol (Oxf): 2013; 208 329 339
38. 2+ channels to coronary pressure-flow autoregulation. Basic Res Cardiol: 2012; 107 264
39. + channels and pulmonary vasoconstriction: role of protein kinase Czeta. Circ Res: 2003; 93 656 663
40. Liu Y., Terata K., Rusch N. J., Gutterman D. D. High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res: 2001; 89 146 152
41. Ajay M., Gilani A. U., Mustafa M. R. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci: 2003; 74 603 612
42. Nishida S., Satoh H. Role of gap junction involved with endothelium-derived hyperpolarizing factor for the quercetin-induced vasodilatation in rat mesenteric artery. Life Sci: 2013; 92 752 756
43. Kaushik D., O'Fallon K., Clarkson P. M., Dunne C. P., Conca K. R., Michniak-Kohn B. Comparison of quercetin pharmacokinetics following oral supplementation in humans. J Food Sci: 2012; 77 H231 H238
44. Moon Y. J., Wang L., DiCenzo R., Morris M. E. Quercetin pharmacokinetics in humans. Biopharm Drug Dispos: 2008; 29 205 217
45. Klockner U., Isenberg G. Intracellular pH modulates the availability of vascular L-type Ca2+ channels. J Gen Physiol: 1994; 103 647 663
46. White R., Hiley C. R. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol: 1997; 122 1573 1584